| In-depth mining of the immunopeptidome of an acute myeloid leukemia cell line using complementary ligand enrichment and data acquisition strategies K Pandey, NA Mifsud, TCCLK Sian, R Ayala, N Ternette, ... Molecular immunology 123, 7-17, 2020 | 20 | 2020 |
| Mycobacterium tuberculosis MymA is a TLR2 agonist that activate macrophages and a TH1 response I Saraav, S Singh, K Pandey, M Sharma, S Sharma Tuberculosis 106, 16-24, 2017 | 19 | 2017 |
| Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach K Pandey, M Sharma, I Saarav, S Singh, P Dutta, A Bhardwaj, S Sharma International Journal of Mycobacteriology 5 (1), 34-43, 2016 | 19 | 2016 |
| Isolation of HLA bound peptides by immunoaffinity capture and identification by mass spectrometry K Pandey, SH Ramarathinam, AW Purcell Current Protocols 1 (3), e92, 2021 | 17 | 2021 |
| Immunopeptidogenomics: Harnessing RNA-seq to illuminate the dark immunopeptidome KE Scull, K Pandey, SH Ramarathinam, AW Purcell Molecular & Cellular Proteomics 20, 2021 | 17 | 2021 |
| Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules I Saraav, K Pandey, M Sharma, S Singh, P Dutta, A Bhardwaj, S Sharma Infection, Genetics and Evolution 44, 182-189, 2016 | 12 | 2016 |
| DosR proteins of Mycobacterium tuberculosis upregulate effector T cells and down regulate T regulatory cells in TB patients and their healthy contacts K Pandey, S Singh, P Bhatt, M Sharma, A Chaudhry, S Sharma Microbial pathogenesis 126, 399-406, 2019 | 8 | 2019 |
| Characterization of MymA protein as a flavin‐containing monooxygenase and as a target of isoniazid I Saraav, K Pandey, R Misra, S Singh, M Sharma, S Sharma Chemical biology & drug design 89 (1), 152-160, 2017 | 6 | 2017 |
| Immunolyser: A web-based computational pipeline for analysing and mining immunopeptidomic data PR Munday, J Fehring, J Revote, K Pandey, M Shahbazy, KE Scull, ... Computational and Structural Biotechnology Journal 21, 1678-1687, 2023 | 5 | 2023 |
| Multi-Omic Analysis of Two Common P53 Mutations: Proteins Regulated by Mutated P53 as Potential Targets for Immunotherapy J Vadakekolathu, DJ Boocock, K Pandey, B Guinn, A Legrand, AK Miles, ... Cancers 14 (16), 3975, 2022 | 5 | 2022 |
| Endogenous H3. 3K27M derived peptide restricted to HLA-A∗ 02: 01 is insufficient for immune-targeting in diffuse midline glioma SS Wang, K Pandey, KA Watson, RC Abbott, NA Mifsud, FM Gracey, ... Molecular Therapy-Oncolytics 30, 167-180, 2023 | 4 | 2023 |
| Defective proinsulin handling modulates the MHC I bound peptidome and activates the inflammasome in β-cells MS Khilji, P Faridi, E Pinheiro-Machado, C Hoefner, T Dahlby, R Aranha, ... Biomedicines 10 (4), 814, 2022 | 4 | 2022 |
| Cell wall-associated Mycobacterium tuberculosis rRv3083 protein stimulates macrophages through toll-like receptor-2 (TLR2) I Saraav, S Singh, K Pandey, E Vishnoi, M Sharma, S Sharma The International Journal of Mycobacteriology 4 (Suppl 1), S176, 2015 | 4 | 2015 |
| A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma K Pandey, SS Wang, NA Mifsud, P Faridi, AJ Davenport, AI Webb, ... Frontiers in Oncology 13, 1192448, 2023 | 2 | 2023 |
| Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes A Braun, LC Rowntree, Z Huang, K Pandey, N Thuesen, C Li, J Petersen, ... Nature Communications 15 (1), 7547, 2024 | 1 | 2024 |
| DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma AM Kirk, JC Crawford, CH Chou, C Guy, K Pandey, T Kozlik, RK Shah, ... Cell Reports Medicine 5 (3), 2024 | 1 | 2024 |
| Endogenous viral elements constitute a complementary source of antigens for personalized cancer immunotherapy C Garde, MA Pavlidis, P Garces, EJ Lange, SH Ramarathinam, M Sokač, ... bioRxiv, 2023.03. 23.533908, 2023 | 1 | 2023 |
| Effect of M. tuberculosis cellwall associated protein rrv3083 on toll like receptor expression in human macrophages I Saraav, S Singh, K Pandey, M Sharma, S Sharma, DS Kothari JOURNAL OF CLINICAL IMMUNOLOGY 35 (3), 308-309, 2015 | 1 | 2015 |
| Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma P Tempora, S D’Amico, P Gragera, V Damiani, K Krol, V Scaldaferri, ... Journal of Experimental & Clinical Cancer Research 43 (1), 292, 2024 | | 2024 |
| Dendritic cell therapy for multiple sclerosis based on promoting Mertk signalling V Li, E Nwoke, K Pandey, A Purcell, M Binder, T Kilpatrick MULTIPLE SCLEROSIS JOURNAL 28 (4_ SUPPL), 9-9, 2022 | | 2022 |
